Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-18

Clinical Trial Update: First Line Therapy for Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for first-line therapy in metastatic breast cancer has terminated; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Celgene | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-07-18